跳转至内容
Merck
CN
  • Homeostatic scaling is driven by a translation-dependent degradation axis that recruits miRISC remodeling.

Homeostatic scaling is driven by a translation-dependent degradation axis that recruits miRISC remodeling.

PLoS biology (2021-11-24)
Balakumar Srinivasan, Sarbani Samaddar, Sivaram V S Mylavarapu, James P Clement, Sourav Banerjee
摘要

Homeostatic scaling in neurons has been attributed to the individual contribution of either translation or degradation; however, there remains limited insight toward understanding how the interplay between the two processes effectuates synaptic homeostasis. Here, we report that a codependence between protein synthesis and degradation mechanisms drives synaptic homeostasis, whereas abrogation of either prevents it. Coordination between the two processes is achieved through the formation of a tripartite complex between translation regulators, the 26S proteasome, and the miRNA-induced silencing complex (miRISC) components such as Argonaute, MOV10, and Trim32 on actively translating transcripts or polysomes. The components of this ternary complex directly interact with each other in an RNA-dependent manner. Disruption of polysomes abolishes this ternary interaction, suggesting that translating RNAs facilitate the combinatorial action of the proteasome and the translational apparatus. We identify that synaptic downscaling involves miRISC remodeling, which entails the mTORC1-dependent translation of Trim32, an E3 ligase, and the subsequent degradation of its target, MOV10 via the phosphorylation of p70 S6 kinase. We find that the E3 ligase Trim32 specifically polyubiquitinates MOV10 for its degradation during synaptic downscaling. MOV10 degradation alone is sufficient to invoke downscaling by enhancing Arc translation through its 3' UTR and causing the subsequent removal of postsynaptic AMPA receptors. Synaptic scaling was occluded when we depleted Trim32 and overexpressed MOV10 in neurons, suggesting that the Trim32-MOV10 axis is necessary for synaptic downscaling. We propose a mechanism that exploits a translation-driven protein degradation paradigm to invoke miRISC remodeling and induce homeostatic scaling during chronic network activity.

材料
Product Number
品牌
产品描述

Roche
不含EDTA的 cOmplete ULTRA Mini 片剂,EASYpack 蛋白酶抑制剂混合物, Tablets supplied in foil blister packs.
Sigma-Aldrich
抗-GAPDH 兔抗, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
磷酸酶抑制剂混合物 1, DMSO solution
Sigma-Aldrich
抗-β微管蛋白III (神经元)抗体,小鼠单克隆 小鼠抗, ~1.0 mg/mL, clone 2G10, purified from hybridoma cell culture
Sigma-Aldrich
抗泛前抗体,克隆2A8, clone 2A8, from mouse
Sigma-Aldrich
抗-GluR2抗体,克隆14C12.2, clone 14C12.2, from mouse